Rifamycin Sodium

CHEMBL2105680 Phase 4 Aprobado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

719.7 g/mol

LogP

—

Phase

4

Rifamycin sodium is the sodium salt form of rifamycin, an ansamycin antibiotic that inhibits bacterial RNA polymerase; the sodium salt formulation improves water solubility for parenteral and oral administration. See rifamycin for complete pharmacological details.

Peso molecular

719,7000 g/mol

TPSA

204,00 Å²

Áreas terapéuticas

Enfermedad de Parkinson Enfermedad infecciosa Insuficiencia cardíaca Tuberculosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c([O-])c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C.[Na+]

InChI

InChI=1S/C37H47NO12.Na/c1-16-11-10-12-17(2)36(46)38-23-15-24(40)26-27(32(23)44)31(43)21(6)34-28(26)35(45)37(8,50-34)48-14-13-25(47-9)18(3)33(49-22(7)39)20(5)30(42)19(4)29(16)41;/h10-16,18-20,25,29-30,33,40-44H,1-9H3,(H,38,46);/q;+1/p-1/b11-10+,14-13+,17-12-;/t16-,18+,19+,20+,25-,29-,30+,33+,37-;/m0./s1

Molecular Formula

C37H46NNaO12

HBD / HBA

5 / 12

Enlaces Rotables

3

Átomos Pesados

51

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

Rifamycin sodium is the sodium salt form of rifamycin, an ansamycin antibiotic that inhibits bacterial RNA polymerase; the sodium salt formulation improves water solubility for parenteral and oral administration. See rifamycin for complete pharmacological details.

Yes, Rifamycin Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105680. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 23702994. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

¿Busca información accesible para el paciente?

Rifamycin Sodium en PillFYI

Estructura

Datos Rápidos

Fórmula: C37H46NNaO12

Enlaces externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.